The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network
J. Chorostowska-Wynimko, A. Kubincova, N. Yanev, R. Ulmeanu, R. Struniawski, P. Pobeha, N. Kyuchukov, O. Deleanu, B. Poplawska-Wisniewska, R. Tkacova, Y. Ivanov, F. Mihaltan, A. Valiulis (Warsaw, Poland; Kosice, Slovakia; Pleven, Bulgaria; Bucharest, Romania; Vilnius, Lithuania)
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chorostowska-Wynimko, A. Kubincova, N. Yanev, R. Ulmeanu, R. Struniawski, P. Pobeha, N. Kyuchukov, O. Deleanu, B. Poplawska-Wisniewska, R. Tkacova, Y. Ivanov, F. Mihaltan, A. Valiulis (Warsaw, Poland; Kosice, Slovakia; Pleven, Bulgaria; Bucharest, Romania; Vilnius, Lithuania). The incidence of severe alpha-1-antitrypsin (AAT) deficiency alleles in COPD patients – Update from Central Eastern European (CEE) AAT Network. Eur Respir J 2014; 44: Suppl. 58, 2035
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: